Global Lung Cancer Impact Challenge

We welcome applications from those seeking to address key challenges in lung cancer and leptomeningeal disease, focusing on:

• Early detection and diagnostic technologies.
• Improved monitoring of disease progression.
• Novel therapeutic approaches that can meet unmet patient needs.
   

Category 1: TRL 0–1

Funding Range:
Up to $200,000 AUD

Project Type:

• Early-stage exploration and foundational research.
• Generating initial data to test novel hypotheses or innovative ideas.
• Discovering new diagnostic biomarkers, therapeutic targets, or disease mechanisms.
• Validating early stage concepts and conducting proof of concept studies.
   

Category 2: TRL 1-2

Funding Range:
Up to $500,000 AUD

Project Type:

• Generating initial data to test novel hypotheses or innovative ideas
• Validating early-stage concepts and conducting proof-of-concept studies.
• Small-scale preclinical experiments or prototype development.
• Refinement of lead molecules, diagnostics, or innovative therapies.
   

Category 3: TRL 2-4

Funding Range:
Up to $1,000,000 AUD

Project Type:

• Validating early-stage concepts and conducting proof-of-concept studies
• Advanced preclinical studies, including animal models, efficacy, and safety evaluations.

Category 4: Large-Scale Transformative Projects (TRL >2)

Focused on projects requiring substantial funding for clinical translation or commercialization.

Funding Range:
Uncapped